ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.102,15
0,75%
S&P 500
5.930,85
1,09%
US Dollar vs BRL
6,0811
-0,08%
Bitcoin
94.073,52
-1,09%
Brent Oil
73,025
0,43%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Enochian Biosciences Inc (ENOB)

  7. Enochian Biosciences Inc (ENOB) Notícias

ENOB

Enochian Biosciences (ENOB)

Enochian Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ENOB
DataHoraFonteTítuloCódigoCompanhia
03/07/202420:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENOBEnochian Biosciences Inc
03/07/202417:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENOBEnochian Biosciences Inc
24/06/202420:56Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
24/04/202418:23Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
13/03/202416:45Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ENOBEnochian Biosciences Inc
16/02/202411:38Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
14/02/202419:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ENOBEnochian Biosciences Inc
16/01/202419:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ENOBEnochian Biosciences Inc
03/01/202410:00Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:ENOBEnochian Biosciences Inc
22/12/202319:25Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:ENOBEnochian Biosciences Inc
30/10/202310:15Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:ENOBEnochian Biosciences Inc
20/10/202322:47Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ENOBEnochian Biosciences Inc
28/06/202308:45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ENOBEnochian Biosciences Inc
23/06/202318:00GlobeNewswire Inc.Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder MeetingNASDAQ:ENOBEnochian Biosciences Inc
08/06/202309:45GlobeNewswire Inc.Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA ReviewNASDAQ:ENOBEnochian Biosciences Inc
19/05/202318:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ENOBEnochian Biosciences Inc
19/05/202318:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ENOBEnochian Biosciences Inc
16/05/202317:35Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ENOBEnochian Biosciences Inc
12/05/202318:27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ENOBEnochian Biosciences Inc
04/04/202317:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ENOBEnochian Biosciences Inc
03/04/202310:00GlobeNewswire Inc.Enochian BioSciences’ CEO Letter to ShareholdersNASDAQ:ENOBEnochian Biosciences Inc
29/03/202310:00GlobeNewswire Inc.Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading ResearcherNASDAQ:ENOBEnochian Biosciences Inc
13/03/202309:30GlobeNewswire Inc.Enochian BioSciences Achieves Full Compliance with NASDAQ Filing RequirementsNASDAQ:ENOBEnochian Biosciences Inc
23/02/202318:04GlobeNewswire Inc.Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022NASDAQ:ENOBEnochian Biosciences Inc
30/11/202219:20GlobeNewswire Inc.Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022NASDAQ:ENOBEnochian Biosciences Inc
15/11/202219:24Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ENOBEnochian Biosciences Inc
24/10/202209:00GlobeNewswire Inc.Enochian BioSciences Forges Ahead With Focused Approach, Promising FutureNASDAQ:ENOBEnochian Biosciences Inc
21/10/202218:00TipRanksEnochian Biosciences receives Nasdaq notice regarding delayed filingNASDAQ:ENOBEnochian Biosciences Inc
21/10/202218:00GlobeNewswire Inc.Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-KNASDAQ:ENOBEnochian Biosciences Inc
17/10/202209:30GlobeNewswire Inc.Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology PlatformNASDAQ:ENOBEnochian Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ENOB

Seu Histórico Recente

BOV
AMBP3
Ambipar Participacoes e ... ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados